21 – 30 of 32
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma
(
- Contribution to journal › Article
- 2005
-
Mark
Obesity, survival, and hospital costs-findings from a screening project in sweden.
(
- Contribution to journal › Article
-
Mark
Cost differences for COPD with and without physician-diagnosis
(
- Contribution to journal › Article
- 2004
-
Mark
A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease
(
- Contribution to journal › Article
- 2003
-
Mark
Budesonide/formoterol in a single inhaler (Symbicort®) reduces healthcare costs compared with separate inhalers in the treatment of asthma over 12 months
(
- Contribution to journal › Article
- 2002
-
Mark
Costs of COPD in Sweden according to disease severity
(
- Contribution to journal › Article